Canvas Wealth Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-1,522
Closed -$304K – 131
2023
Q3
$304K Sell
1,522
-250
-14% -$52.7K 0.13% 92
2023
Q2
$333K Buy
1,772
+9
+0.5% +$1.75K 0.12% 92
2023
Q1
$340K Sell
1,763
-6
-0.3% -$1.24K 0.14% 97
2022
Q4
$382K Buy
1,769
+10
+0.6% +$1.95K 0.16% 96
2022
Q3
$347K Buy
1,759
+7
+0.4% +$1.43K 0.15% 88
2022
Q2
$353K Buy
1,752
+6
+0.3% +$1.28K 0.14% 90
2022
Q1
$368K Sell
1,746
-12
-0.7% -$2.82K 0.13% 107
2021
Q4
$474K Hold
1,758
– – 0.17% 92
2021
Q3
$425K Buy
1,758
+6
+0.3% +$1.51K 0.17% 84
2021
Q2
$415K Buy
1,752
+6
+0.3% +$1.37K 0.19% 84
2021
Q1
$383K Buy
+1,746
New +$350K 0.22% 75

Other funds holding LH

Canvas Wealth Advisors's LH Position: Q4 2023 in Review

Canvas Wealth Advisors sold out of Labcorp (LH) in Q4 2023, closing a stake of 1,522 shares — an estimated $304K sold.

Canvas Wealth Advisors first reported a position in LH in Q1 2021 and held it in 11 quarters. The position peaked at $474K in Q4 2021. 957 funds tracked by Wall St. Rank hold LH as of Q4 2023.

  • Canvas Wealth Advisors reported no remaining Labcorp position as of Q4 2023 after selling out during the quarter.
  • Canvas Wealth Advisors sold 1,522 Labcorp shares in Q4 2023, an estimated $304K.
  • Canvas Wealth Advisors first reported a position in Labcorp in Q1 2021 and held it in 11 quarters.
  • Canvas Wealth Advisors's Labcorp position peaked at $474K in Q4 2021.
  • 957 funds tracked by Wall St. Rank held Labcorp as of Q4 2023.

Based on Canvas Wealth Advisors's 13F filing for Q4 2023, filed 17 Jan 2024.